Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

31 results about "Halcinonide" patented technology

This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash).

Ointment for treating gynaopathy and dermatoses and preparation method thereof

The invention discloses an ointment for treating gynaopathy and dermatoses and a preparation method thereof. The externally-applied ointment is prepared from halcinonide preparation, menthol crystal and camphor which are utilized as raw materials according to a certain preparation technology, and is prepared from the following raw materials in parts by weight: 6 to 6.5 parts of halcinonide preparation, 15 to 20 parts of menthol crystal, 15 to 20 parts of camphor, 3 to 3.5 parts of edetate disodium, 20 to 40 parts of polyethylene glycol mono stearate, 0 to 3 parts of essence, 0 to 2 parts of carbomer, 0 to 2 parts of sodium bicarbonate and 15 to 25 parts of pure water. The externally-applied ointment is low in cost, has the effects of clearing away heat, eliminating dampness, dispelling the wind, killing worms, diminishing inflammation and relieving itching, has better treatment effects, has the characteristics of being easy to prepare, lower in cost and obvious in treatment effect, and can be used for treating the gynaopathy, such as vaginitis, cervicitis and cervical erosion, caused by various germs, and treating the dermatoses, such as tinea corporis, tinea cruris, tinea of feetand hands and various dermatitis, caused by various fungus infection. The externally-applied ointment has exact treatment effects, takes effect rapidly, is low in cost and convenient to use, and has no toxic and side effects, thus being worthy of popularization and application.
Owner:李怀珠

Preparation method of halcinonide and derivative thereof

The invention provides a preparation method of halcinonide and a derivative thereof. The method comprises the following steps: taking hydrocortisone acetate as a raw material, performing dehydration and then epoxidation on the raw material, performing ring opening, performing hydrolysis and chlorination, and then performing oxidation and ketalization, so as to obtain halcinonide; or performing dehydration and then epoxidation on the raw material, performing ring opening, performing hydrolysis, and then performing oxidation and ketalization, so as to obtain 9-fluoro-16a,17-(isopropylidenedioxy)corticosterone. In ring opening fluorination unit reaction, safe and mild reaction environment is selected, a fluorizating agent with low concentration is used as a reaction reagent, the reaction rate is effectively controlled, the production of side reaction products is restrained, and the product quality and yield are greatly improved. Moreover, in 16, 17-ketalization unit reaction, an acid catalyst which is low in toxicity and easy to control is adopted to replace boron trifluoride with high toxicity to perform catalysis, and the catalytic effect is effectively improved.
Owner:SHANDONG TAIHUA BIO & TECH

Preparation method of halcinonide

The invention provides a preparation method of halcinonide. The method includes: (1) chlorination reaction: in the presence of SO2, reacting a compound 1 with a chlorination reagent to generate a compound 2, with the chlorination reagent being selected from one or more of acetyl chloride, propionyl chloride, benzoyl chloride, lithium chloride, carbon tetrachloride, chlorosuccinimide and dichloro dimethylhydantoin; and (2) ring-opening reaction: reacting the compound 2 with hydrogen fluoride to obtain halcinonide. The method provided by the invention has the beneficial effects of mild reactionconditions, friendly environment, easy operation and low cost, has industrialization value, can effectively control side reaction, and improve the reaction yield and quality; the process design does not involve high-risk reaction, and is easy to realize industrialization; high-pollution reaction does not exist, thus easing the pressure of environmental protection treatment.
Owner:TIANJIN PHARMA GROUP CORP

Liquid medicine for relieving itching aiming at a variety of skin diseases and preparation method thereof

The invention belongs to the technical field of medicine and discloses a liquid medicine for relieving itching of various skin diseases, and a preparation method thereof in particular. The liquid medicine for relieving itching of various skin diseases is prepared by the following materials: sulfur, borneol, camphor, pricklyash peel, sessile stemona root, belvedere fruit, halcinonide solution, and medicinal alcohol B. The preparation method comprises the following steps: after the six medicines of sulfur, borneol, camphor, pricklyash peel, sessile stemona root and Belvedere fruit are ground into powder, halcinonide liquid is added then, and finally the obtained mixture is added into the medical alcohol B together for dipping for 24 to 48 hours. The materials of the invention are easily obtained and the preparation method is simple. The liquid medicine is preferentially prepared into a lotion and arrives the affected part directly to exert the effects of disinsection, rheumatism and itching relief, and sterilization; simultaneously the liquid medicine can stimulate the skin and improve the microcirculation and the regulation functions of human bodies, thereby removing pathological changes. A plurality of clinic treatment effects prove that the liquid medicine has wide application range, the cure rate of more than 95 percent, and extremely good effects.
Owner:周大红

Preparation process of halcinonide intermediate

The invention provides a prepration process of a halcinonide intermediate. The preparation process comprises the steps: taking a hydrofluoric acid-acetone mixed solvent as a solvent, slowly adding an intermediate N-3 at subzero 40 DEG C to subzero 30 DEG C, carrying out reaction for 4 to 8 hours after material feeding is completed, enabling the temperature to return to subzero 5 DEG C to 0 DEG C, continuously carrying out reaction for 10 to 30 min, slowly adding reaction fluid into a potassium carbonate solution after the reaction is completed, adjusting the PH value to 7.0 to 7.5, filtering and discharging a product, and drying the product to obtain the halcinonide intermediate with the structure as shown in formula N-5. According to the preparation process, a one-pot method is adopted for production, so that the production steps are effectively simplified, and the production period is shortened; the preparation process is more environment-friendly.
Owner:HENAN LIHUA PHARMA

Halcinonide preparation method

The invention provides a brand-new synthesis route for preparing halcinonide. Used raw materials are cheaper and available. The method comprises the steps that: the reacted raw materials are hydroxylated and then chlorinated, selective oxidation of a five-membered ring double bond is conducted, a carbonyl protecting group is removed, an oxidized dihydroxyl group is protected, then a six-membered ring double bond is epoxidized, an open ring is fluoridized so as to obtain a halcinonide product. The reaction process is easy to operate, yield is higher in each step, purity of the obtained productis also higher, formation of byproducts is effectively avoided, production cost is reduced, and the method is advantageous to industrial production.
Owner:TIANJIN PACIFIC PHARMA

Medicinal composition for treating skin disease and its preparing method

InactiveCN1813771AObvious synergyPreserve anti-inflammatory effectsOrganic active ingredientsAntimycoticsDiseaseBetamethasone valerate
The present invention discloses a medicine composition for curing dermopathy and its preparation method. Said medicine composition contains the following components: (by weight portion) 0.3-3.0 portions of naftifine and 0.005-0.50 portion of one component selected from halcinonide, triamcinolone acetonide acetate, betamethasone (containing betamethasone propionate and betamethasone valerate) or clobetasol propionate. Said medicine composition can be made into various medicine preparations for external application.
Owner:YAKEXI PHARMA INST BEIJING

Synergistic pharmaceutical compositions

[A pharmaceutical composition comprises a synergistic combination of about 0.01-0.15% by wt. triamcinolone acetonide and about 0.04-0.3% by wt. halcinonide as active ingredients, in combination with a pharmaceutically acceptable carrier.]A pharmaceutical composition comprises a synergistic combination of at least about 0.01% by wt. triamcinolone acetonide and at least about 0.01% by wt. halcinonide as active ingredients therein, in combination with a pharmaceutically acceptable carrier.
Owner:PSORIAL

Medicine composition for treating gastric ulcer

The invention discloses a medicine composition for treating gastric ulcer. The medicine composition for treating gastric ulcer comprises the following main raw materials in parts by weight: 20-30 parts of astragalus extract, 5-15 parts of radix paeoniae alba extract, 8-12 parts of halcinonide, 8-14 parts of tea polyphenol, 4-6 parts of calcium gluconate, 17-23 parts of formononetin, 8-15 parts of ginkgolides, 2-7 parts of Schisantherin and 3-9 parts of rutin. The medicine has anti-inflammation and stomach restoration capability so as to achieve the complete recovery purpose, can treat both symptoms and roots causes, and is fast in effect, low in toxic and side effects and low in cost.
Owner:ZHENGZHOU ZHANGMENG NETWORK TECH CO LTD

Method for quantitatively testing halcinonide in cosmetics

InactiveCN101303359AMeet the testing requirements of hormone limitAvoid interferenceComponent separationBiological testingLiquid layerCentrifugation
The invention discloses a method for the quantitative detection of halcinonide in cosmetics, which comprises the steps that: 1) halcinonide and butenolide II are added into chromatographic methanol to obtain a reference substance; 2) a butenolide II methanol solution is added into a centrifuge tube and then cosmetics to be detected are added into the centrifuge tube which is dried in a manner of blow; 3) an extraction reagent is added; 4) centrifugation is carried out to obtain all organic phase solutes; 5) the organic phase solutes are dissolved in a mobile phase and a liquid layer is obtained after centrifugation; 6) the reference substance obtained by the step 1) and the liquid layer by the step 5) are carried out high efficiency liquid chromatographic analysis respectively; 7) the content of halcinonide in cosmetics to be detected is equal to the absorption peak area ratio of the halcinonide and the butenolide II in the liquid layer which is multiplied by the concentration of the halcinonide in the reference substance and divided by the absorption peak area ratio of the halcinonide and the butenolide II in the reference substance. The method for halcinonide detection provided by the invention has the advantage of high accuracy.
Owner:CHINA JILIANG UNIV

Medicine for treating beriberi

The invention relates to a medicine for treating beriberi, which is prepared by evenly mixing and stirring neomycin sulfate cream, a halcinonide solution and iodine tincture after being proportioned according to the weight percent. The invention has especially obvious curative effect, only needs to be applied for 1-2 times in the pullulation state of beriberi infection, only needs to be applied for 10-15 days for treating the beriberi of 3-5 years, also needs only to be applied for about one month for thoroughly curing the beriberi of more than 10 years and has no relapse of one case.
Owner:刘太平

Medicine for treating dermatosis

The invention relates to a medicine, in particular to a medicine for treating skin diseases. The invention provides a kind of medicine for treating skin disease, and its medicinal effect component is made up of the raw material medicine of following parts by weight: Halcinonide 0.2-1.6; Prednisone acetate 2-10; Diphenhydramine hydrochloride 0.1-0.6; Chlorine Mycin 80-160; Griseofulvin 30-120; Sulfur 100-260; Dexamethasone 0.5-1.0. The invention also provides a preparation method of the medicine for treating skin diseases. The product of the invention is suitable for skin diseases caused by various fungal infections, can promote skin cell protein synthesis, and promote healing. Clinical application observation data shows that the product of the present invention has a treatment rate of 95% and an effective rate of 100%.
Owner:邵杰

Medicine for treating beriberi

The invention relates to a medicine for treating beriberi, which is prepared by evenly mixing and stirring neomycin sulfate cream, a halcinonide solution and iodine tincture after being proportioned according to the weight percent. The invention has especially obvious curative effect, only needs to be applied for 1-2 times in the pullulation state of beriberi infection, only needs to be applied for 10-15 days for treating the beriberi of 3-5 years, also needs only to be applied for about one month for thoroughly curing the beriberi of more than 10 years and has no relapse of one case.
Owner:刘太平

Halcinonide producing process

InactiveCN1142176CLess impuritiesImproved yield qualitySteroidsHydrogen fluorideDissolution
The present invention is the production process of fluorizing Halcinonide with intermediate condensating and reducing as material. The technological process incldues fluorizing reaction with hydrogen fluoride and dimethyl methane amide solution, dilution with great amount of water, neutralization with ammonia water, filtering, and drying; recrystallization to refine through dissolution with mixed solvent of chloroform and methanol, concentration, addition of methanol for recrystallization; and filtering and drying to obtain the fluorized Halcinonide product. The said technological process has high yield and quality of the fluorized product.
Owner:天津药业集团有限公司

Halcinonide cream

Halcinonide cream is provided. The halcinonide cream comprises halcinonide adopted as the active component, solid in oil-phase components, a consistency modifier, a humectant, an emulsifier, an aseptic and water, and is characterized by also comprising edetate calcium disodium.
Owner:TIANJIN JINYAO GRP

Medicinal frost formulation for treating psoriasis and its preparing process

The invention provides a medicinal frost formulation for treating psoriasis and its preparing process, wherein the formulation is prepared from the following constituents (by weight proportions), aitan part, erythromycin ointment 33 parts, Triamcinolone ointment 33 parts, Halcinonide emulsifiable paste 33 parts, and is prepared through mixing and modulation.
Owner:周春来

Culture solution and culture method of umbilical cord blood NK cells

The invention discloses a culture solution and a culture method of umbilical cord blood NK cells. The culture solution comprises the following components: a first culture medium and a second culture medium, wherein the first culture medium is formed by adding cell factors IL-2, IL-15, IL-12, SCF, TGF, PDGF, OK432, StemRegenin 1 and halcinonide into a basic culture medium; the second culture medium is formed by adding cell factors IL-2, IL-21, SCF, soyabean lecithin, soyabean lecithin and thymopentin into the basic culture medium; the third culture medium is formed by adding cell factors IL-2, SCF, soybean lecithin and thymopentin into the basic culture medium. The cell factors are added into the culture solution, so that the cell culture period is shortened by 37.5%, and meanwhile, the amplification multiple, the purity and the tumor killing effect of the NK cells are improved.
Owner:GUANGDONG XIANKANGDA BIOTECH CO LTD

Medicine for treating gastric ulcer

The invention discloses a medicine for treating gastric ulcer. The medicine for treating gastric ulcer is prepared from the following principal raw materials in parts by weight: 23-28 parts of calcium carbonate, 5-15 parts of atropine sulfate, 8-12 parts of halcinonide, 8-14 parts of choline theophyllinate, 4-6 parts of calcium gluconate, 17-23 parts of formoononetin, 8-15 parts of bilobalide C, 2-7 parts of schisantherin and 3-9 parts of rutin. The medicine disclosed by the invention has the effects of diminishing inflammation and repairing the stomach, so that the purpose of comprehensive rehabilitation can be achieved, the symptoms and root causes all can be treated, the course of treatment is short, the medicine can quickly become effective, the toxic or side effect is little and the cost is very low.
Owner:郑州莉迪亚医药科技有限公司

Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them

InactiveCN108430457AOrganic active ingredientsPeptide/protein ingredientsMometasoneFluocinolone
This invention relates to a nanoliposome comprising at least one outer lipid bilayer and at least one corticosteroid encapsulated bythe at leastone lipid bilayer, wherein the ratio of the corticosteroid and lipids forming the lipid bilayer is preferably between 0.01 - 0.5, 0.1 - 0.3 or 0.12 - 0.18. The corticosteroid may be a group B corticosteroid, including triamcinolone acetonide, fluocinoloneacetonide, triamcinolone alcohol, mometasone, amcinonide, budesonide, desonide, fluocinonide and halcinonide. Preferably, the size of the nanoliposome is between 1 0 - 1 000 nm or 50 - 150 nm. The present invention also relates to the use of the nanoliposome of the invention for use as a medicam ent and for use in the treatment of a cardiovascular disease. Further, the invention is directed to a method to prepare the nanoliposome of the invention, which may further include an extruding step.
Owner:NANYANG TECH UNIV

Application of halcinonide and derivative thereof in preparation of medicine for treating and/or preventing cerebrovascular diseases

The invention relates to the technical field of medicines, in particular to application of halcinonide and a derivative thereof in preparation of a medicine for treating and / or preventing cerebrovascular diseases. The halcinonide and the derivative thereof have a structural general formula shown in formula (I), and the treatment effect of the halcinonide and the derivative thereof on ischemic cerebral stroke is evaluated through an MCAO cerebral ischemia-reperfusion injury animal model. Experimental results show that the halcinonide and the derivatives thereof prednisone and testosterone propionate can significantly improve the score of animal neurological impairment and reduce the area of infarct focus, can be used for treating ischemic stroke, and have good clinical application prospects.
Owner:上海普佑生物医药有限公司

A medicine for treating dermatosis

The invention discloses a medicament for treating skin diseases, wherein the effective constituents comprise the following raw materials (by weight ratio): Halcinonide 0.2-1.6, prednisone acetate 2-10, diphenhydramine hydrochloride 0.1-0.6, aquamycetin 80-160, spirofulvin 30-120, sulfur 100-260 and decacortin 0.5-1.0. The invention also provides the process for preparing the pharmaceutical composition.
Owner:李中变

Skin disease treating medicine

The invention relates to medicines, in particular to a skin disease treating medicine. The skin disease treating medicine comprises raw medicinal materials in parts by weight as follows: 0.2-1.6 partsof halcinonide, 2-10 parts of prednisone acetate, 0.1-0.6 parts of diphenhydramine hydrochloride, 80-160 parts of chloramphenicol, 30-120 parts of griseofulvin, 100-260 parts of sulfur and 0.5-1.0 part of dexamethasone. The invention further provides a preparation method of the skin disease treating medicine. The medicine is applicable to skin diseases caused by various fungal infection and can promote cell protein synthesis and healing. Clinical application observation data shows that the medicine has the treatment rate of 95% and the effective rate of 100%.
Owner:吴定

Ointment for treating gynaopathy and dermatoses and preparation method thereof

The invention discloses an ointment for treating gynaopathy and dermatoses and a preparation method thereof. The externally-applied ointment is prepared from halcinonide preparation, menthol crystal and camphor which are utilized as raw materials according to a certain preparation technology, and is prepared from the following raw materials in parts by weight: 6 to 6.5 parts of halcinonide preparation, 15 to 20 parts of menthol crystal, 15 to 20 parts of camphor, 3 to 3.5 parts of edetate disodium, 20 to 40 parts of polyethylene glycol mono stearate, 0 to 3 parts of essence, 0 to 2 parts of carbomer, 0 to 2 parts of sodium bicarbonate and 15 to 25 parts of pure water. The externally-applied ointment is low in cost, has the effects of clearing away heat, eliminating dampness, dispelling the wind, killing worms, diminishing inflammation and relieving itching, has better treatment effects, has the characteristics of being easy to prepare, lower in cost and obvious in treatment effect, and can be used for treating the gynaopathy, such as vaginitis, cervicitis and cervical erosion, caused by various germs, and treating the dermatoses, such as tinea corporis, tinea cruris, tinea of feetand hands and various dermatitis, caused by various fungus infection. The externally-applied ointment has exact treatment effects, takes effect rapidly, is low in cost and convenient to use, and has no toxic and side effects, thus being worthy of popularization and application.
Owner:李怀珠

Preparation method of halcinonide and intermediate thereof

PendingCN113493486AProcess method energy saving and consumption reductionSimplify production stepsSteroidsSulfonyl chlorideChlorobenzene
The invention provides a preparation method of halcinonide and an intermediate thereof. The preparation method of the halcinonide intermediate (namely a compound of a formula N-7) comprises the following steps: carrying out a chlorination reaction on a compound of a formula N-3 and a chlorination reagent, and then carrying out a fluorination reaction with a fluorine-containing reagent, wherein the reaction formula is disclosed in the invention, the chlorination reagent is selected from sulfonyl chloride of aromatic hydrocarbon and is specifically selected from at least one of benzene sulfonyl chloride, p-toluenesulfonyl chloride and p-chlorobenzene sulfonyl chloride, and the fluorine-containing reagent is hydrofluoric acid. The preparation method is efficient, green and environmentally friendly, the production period is shortened, a large amount of wastewater is reduced, the yield is improved, the production cost is reduced, clean production is achieved, the HPLC content of the halcinonide product reaches 99.0% or above, the content of any impurity is smaller than 0.10%, and the yield reaches 100% or above.
Owner:HENAN LIHUA PHARMA

Application of biomarker in screening and diagnosis of sexual precocity of children

The invention provides application of a biomarker in preparation of a product for screening and diagnosing sexual precocity of children. The biomarker is prepared from one or more of halcinonide, corticosterone, cortisone, 11-deoxycorticosterone, 11-deoxycortisol, 17 alpha-hydroxyprogesterone, betasone butyrate, fludrocortisone acetate, methylprednisolone acetate, prednisolone acetate, hydrocortisone valerate, methyltestosterone and androstenedione (steroid). According to the application, a plurality of child samples are measured, and the result shows that specific compounds have significant difference between healthy children and precocious children, and the T test P value is less than 0.1, which shows that the contents of the compounds have significant difference. Therefore, the compounds with significant difference can be used as diagnostic markers for screening and diagnosing early sexual precocity of children.
Owner:上海血液生物医药有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products